Cigarette smoking represents the single most preventable cause of premature morbidity and mortality in the United States and the burden of tobacco use is apparent world-wide. Cigarette smoking is a major risk factor for chronic obstructive pulmonary disease, the third leading cause of death in the United States in 2004. The American Thoracic Society (ATS) and its members have contributed significantly to an understanding of the biological and pathophysiologic mechanisms responsible for the development and management of tobacco-attributable disease and disability. The society's active involvement in tobacco control advocacy and policy-related initiatives are central to its mission. Within the ATS, there is also increased interest in accelerating the society's efforts to understand the mechanisms responsible for the uptake, persistence, and cessation of tobacco use. Scientific, clinical, and educational activities that include an examination of these underlying mechanisms are warranted. This paper describes findings from an ATS initiative that developed a preliminary strategy for enhancing scientific, clinical, educational, and policy-related tobacco control efforts that are consistent with the vision of the ATS. The specific aims of this project included the identification of existing mechanisms, as well as the current governance in place within the ATS infrastructure, to address tobacco control issues related to scientific inquiry, policy initiatives, and advocacy for tobacco control. This assessment generated recommendations to inform the ATS leadership with regard to the future development of relevant tobacco control initiatives.
INTRODUCTION
That so many diseases, major and minor, should be related to smoking is one of the most astonishing findings of medical research in this century . . . less astonishing perhaps than the fact that so many people have ignored it. (Sir Richard Doll, 1999) (1) Cigarette smoking and other forms of tobacco use represent the single most preventable cause of premature morbidity and mortality in the United States (2) . Tobacco use is responsible for more than one in five deaths in the United States; over 30% of all cancers are due to tobacco, with cigarette smoking responsible for 87% of lung cancer deaths (3) . It is well documented that cigarette smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. In 2001, it was estimated that approximately 12 million U.S. adults had COPD (4) . (5), and during this time the annual number of deaths from COPD increased 5% and 11%, for men and women, respectively. In sum, tobacco use is responsible for nearly 80% of all COPD deaths (3) . Exposure to second-hand smoke is also associated with a variety of health conditions (6) . Nonsmokers who are exposed to second-hand smoke in the home or at work increase their risk of developing lung cancer by as much as 30%. Second-hand smoke causes bronchitis and pneumonia among infants and children, and increases the risk of ear infections. Children with asthma who are exposed to second-hand smoke experience more frequent and severe attacks. Approximately 15 to 25% of all hospitalizations of infants and children with lower respiratory illnesses (bronchitis and pneumonia) were due to second-hand smoke exposure (7) . Parental smoking results in annual direct medical expenditures of $4.6 billion for American children (8) . Overall, the health costs of tobacco use in the United States alone are estimated at $193 billion annually, with about $96 billion in direct medical costs and approximately $97 billion in lost productivity (3) . Of note, in 2007 only $595 million was invested in comprehensive U.S. state-based tobacco prevention and control programs (3) .
Globally, the tobacco epidemic is staggering. According to the World Health Organization (9) , tobacco use is the second major cause of death in the world; it claims one in ten worldwide (about 5 million deaths each year). More importantly, if current smoking patterns continue, it is estimated that by 2020, 10 million deaths will occur each year. Half the people that smoke today, about 650 million people, will eventually be killed by tobacco. Smoking accounts for 5.1 million years of potential life lost in the United States each year (3) . Among developing countries, this loss will create significant effects for fragile economic markets.
Professional health societies whose members care for patients and conduct basic or clinical research related to tobaccoattributable diseases have dedicated their efforts toward understanding and alleviating the effects of tobacco use. While not exhaustive, the list of these societies or associations include the American Cancer Society, the American Lung Association, the American Heart Association, the European Respiratory Society, and the American Thoracic Society.
As an example, the American Thoracic Society (ATS) is recognized as a premier organization with interests in all respiratory, critical care, and sleep-related health conditions. The ATS is dedicated to the belief that ''scientific inquiry is the solution to the threats to human health'' (10) . Tobacco use represents one of the most striking threats, and ATS members have contributed significantly to an understanding of the biological and pathophysiologic mechanisms responsible for the development of tobacco-attributable disease and disability. The ATS has been a leader in promoting an understanding of the pathogenesis of tobacco-attributable diseases. Given these accomplishments, it would be wise to also use the talent within professional health societies like the ATS to investigate mechanisms responsible for the uptake, persistence, and cessation of smoking. These root mechanisms of tobacco use merit increased emphasis, as tobacco consumption is responsible for a significant proportion of lung disease. Clinical, educational, and scientific efforts that include investigations to examine the root mechanisms responsible for the initiation and continuing use of tobacco, as well as testing the efficacy of tobacco dependence treatment, are warranted. In addition, professional health societies, like the ATS, often have a central mission of tobacco control advocacy and policy initiatives. Health services research, policy-related studies, and advocacy efforts that influence the treatment of smokers deserve attention from professional health societies that have tobacco control as an area of focus.
Before ATS' separation from the American Lung Association (ALA) in 2000, tobacco control efforts were emphasized within the ALA arm of the organization. Since separation, less attention has been directed within the ATS at understanding the social, biological, behavioral, and policy-related factors responsible for the uptake, persistence, and cessation of tobacco use. Given that the ATS defines its vision as the ''dedication to a spirit of inquiry as the principal means for preventing respiratory disease and advancing patient care'' (10), additional emphasis must be directed at the investigation of persistent tobacco use.
The purpose of this report is to describe an initiative funded by the ATS in 2007 that charged a subcommittee to develop a preliminary strategy for enhancing scientific, clinical, educational, and policy-related tobacco control efforts that are consistent with the vision of the ATS, that is, ''working toward a world without lung disease'' (10) . The specific aims of the project included the identification and review of existing mechanisms, as well as the current governance in place within the ATS infrastructure to address tobacco control issues related to scientific inquiry, tobacco policy initiatives, and tobacco control advocacy. This assessment was intended to inform the ATS with regard to the future need to develop relevant tobacco control initiatives.
METHODS
Each of the twelve ATS assemblies that existed in 2007 was invited to nominate a representative to the subcommittee. The final subcommittee was composed of representatives from seven ATS assemblies. The specific aims were accomplished during four conference calls and one face-to-face meeting at the ATS International Conference in San Francisco in 2007. Described below are the aims and methods used to obtain information about each aim. 
RESULTS
The activities associated with each of six aims were assigned to a specific committee member who was responsible for completing the assignment and presenting the findings to the full committee. Working as a whole, the workgroup used a consensusbased approach to develop specific recommendations for enhancing tobacco control efforts within the ATS. Next, the proposed recommendations were voted upon. Final recommendations (to follow) were endorsed unanimously by the full committee. Subsequently, the workgroup chair was charged with writing the final workshop report to be reviewed by the full committee, again for endorsement, before submission to the ATS Board of Directors. Presented below in Table 1 is a summary of findings related to the specific aims of the project, followed by recommendations from the workgroup.
CONCLUSIONS
The ATS leadership is to be congratulated for efforts to examine the Society's tobacco control initiatives with the goal of eliminating the tobacco-attributable burden of lung disease. As the Society continues to expand and transform, it is crucial to accelerate tobacco control efforts. According to a recent Institute of Medicine report entitled Ending the Tobacco Problem: A Blueprint for the Nation (11), it is projected that if a status quo approach is maintained, the prevalence of tobacco use in the year 2025 (U.S. alone) will be approximately 16%, compared with 20.9% today. This discouragingly slow rate of decline in adult tobacco use prevalence mandates that the scientific community, including the American Thoracic Society, participate more fully in: (1) the investigation of the root causes of tobacco use, (2) the treatment of nicotine dependence, and (3) advocacy efforts to eliminate its use. As website are difficult to find 6. ACCP has formal CME education curriculum and includes ''Tobacco Cessation and Prevention'' (Continued) a first step, the subcommittee strongly endorsed as its most critical recommendation the creation of a formal and sustainable entity (e.g., committee, section, etc.) that is charged with fostering tobacco control research initiatives, training activities, and advocacy efforts within the ATS organization. This entity provides the necessary infrastructure to implement the comprehensive listing of recommendations put forth is this document. The ATS vision of ''a world without lung disease'' will only be achieved through dedicated and focused efforts to eliminate tobacco use. These recommendations represent the next logical step toward eliminating the burden of tobacco-attributable respiratory diseases. Whether these recommendations are sufficiently comprehensive in leading to meaningful change in tobacco control is unknown; however, the strategies advance the society's efforts to prioritize the agenda of tobacco control. Vigilant monitoring on the part of the ATS is needed to determine whether these recommendations promote the desired change and assist with the vision of achieving a world without lung disease. 
